JANX Competitors & Alternatives
Compare Janux Therapeutics Inc with similar stocks in the same industry
Biotechnology
JANX
Main Stock$16.73
Tradestie Score
43
Market Cap
$1.42B
Revenue Growth
21.8%
Analyst Upside
+116.6%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NKTR
Nektar Therapeutics
|
$37.22
|
$1.12B | - | 62 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$253.92
|
$1.12B | - | 65 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$7.35
|
$1.09B | - | 55 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$10.80
|
$1.05B | 74.2 | 40 | Compare |
|
MDXG
MiMedx Group, Inc
|
$3.87
|
$1.01B | 93.5 | 47 | Compare |
|
PRME
Prime Medicine, Inc. Common Stock
|
$3.62
|
$996.55M | - | 43 | Compare |
|
SYRE
Spyre Therapeutics, Inc. Common Stock
|
$90.67
|
$994.20M | - | 37 | Compare |
|
VALN
Valneva SE American Depositary Shares
|
$5.25
|
$993.46M | - | 52 | Compare |
|
IMNM
Immunome, Inc.
|
$17.90
|
$987.09M | - | 59 | Compare |
|
SANA
Sana Biotechnology, Inc. Common Stock
|
$2.31
|
$951.83M | - | 59 | Compare |
More JANX Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry